Bal Pharma Limited (BOM:524824)

India flag India · Delayed Price · Currency is INR
76.04
+0.27 (0.36%)
At close: Apr 28, 2026
-28.08%
Market Cap 1.21B
Revenue (ttm) 3.09B
Net Income (ttm) 81.23M
Shares Out 15.92M
EPS (ttm) 4.82
PE Ratio 15.78
Forward PE n/a
Dividend 1.20 (1.58%)
Ex-Dividend Date Sep 18, 2025
Volume 523
Average Volume 1,123
Open 75.40
Previous Close 75.77
Day's Range 75.40 - 77.50
52-Week Range 59.69 - 112.97
Beta 0.35
RSI 54.83
Earnings Date May 29, 2026

About Bal Pharma

Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic p... [Read more]

Industry Pharmaceutical Preparations
Founded 1987
Employees 986
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524824
Full Company Profile

Financial Performance

In fiscal year 2025, Bal Pharma's revenue was 3.03 billion, a decrease of -10.65% compared to the previous year's 3.39 billion. Earnings were 72.15 million, a decrease of -2.39%.

Financial Statements

News

There is no news available yet.